Home Cart Sign in  
Chemical Structure| 13093-04-4 Chemical Structure| 13093-04-4

Structure of 13093-04-4

Chemical Structure| 13093-04-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Li, Bowen ; Manan, Rajith Singh ; Liang, Shun-Qing ; Gordon, Akiva ; Jiang, Allen ; Varley, Andrew , et al.

Abstract: The expanding applications of nonviral genomic medicines in the lung remain restricted by delivery challenges. Here, leveraging a high-throughput platform, we synthesize and screen a combinatorial library of biodegradable ionizable lipids to build inhalable delivery vehicles for mRNA and CRISPR-Cas9 gene editors. Lead lipid nanoparticles are amenable for repeated intratracheal dosing and could achieve efficient gene editing in lung epithelium, providing avenues for gene therapy of congenital lung diseases.

Alternative Products

Product Details of [ 13093-04-4 ]

CAS No. :13093-04-4
Formula : C8H20N2
M.W : 144.26
SMILES Code : CNCCCCCCNC
MDL No. :MFCD00008293
InChI Key :MDKQJOKKKZNQDG-UHFFFAOYSA-N
Pubchem ID :83131

Safety of [ 13093-04-4 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H227-H315-H319-H335
Precautionary Statements:P210-P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P370+P378-P403+P233-P403+P235-P405-P501

Application In Synthesis of [ 13093-04-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 13093-04-4 ]

[ 13093-04-4 ] Synthesis Path-Downstream   1~35

  • 1
  • [ 75-15-0 ]
  • [ 13093-04-4 ]
  • [ 109254-97-9 ]
  • 2
  • [ 75-15-0 ]
  • [ 13093-04-4 ]
  • [ 75854-55-6 ]
  • 3
  • [ 75-44-5 ]
  • [ 13093-04-4 ]
  • [ 110571-18-1 ]
  • 4
  • [ 3397-62-4 ]
  • [ 13093-04-4 ]
  • [ 109337-19-1 ]
  • 5
  • [ 13093-04-4 ]
  • [ 2834-05-1 ]
  • 11-[methyl-(6-methylamino-hexyl)-amino]-undecanoic acid [ No CAS ]
  • 6
  • [ 13093-04-4 ]
  • [ 1940-57-4 ]
  • [ 63834-53-7 ]
  • 7
  • [ 102600-37-3 ]
  • [ 13093-04-4 ]
  • 8
  • [ 13093-04-4 ]
  • [ 541-41-3 ]
  • [ 67549-12-6 ]
  • 10
  • [ 629-03-8 ]
  • [ 74-89-5 ]
  • [ 13093-04-4 ]
  • 11
  • [ 111-25-1 ]
  • [ 13093-04-4 ]
  • [ 71181-77-6 ]
  • 12
  • [ 111-83-1 ]
  • [ 13093-04-4 ]
  • [ 58295-98-0 ]
  • 13
  • [ 693-58-3 ]
  • [ 13093-04-4 ]
  • [ 71181-83-4 ]
  • 14
  • [ 693-58-3 ]
  • [ 13093-04-4 ]
  • [ 71181-78-7 ]
  • 15
  • [ 112-29-8 ]
  • [ 13093-04-4 ]
  • [ 71181-84-5 ]
  • 16
  • [ 112-29-8 ]
  • [ 13093-04-4 ]
  • [ 71181-79-8 ]
  • 17
  • [ 13093-04-4 ]
  • [ 765-09-3 ]
  • [ 71181-87-8 ]
  • 18
  • [ 13093-04-4 ]
  • [ 765-09-3 ]
  • [ 71181-81-2 ]
  • 19
  • [ 13093-04-4 ]
  • [ 112-71-0 ]
  • [ 71181-88-9 ]
  • 20
  • [ 13093-04-4 ]
  • [ 112-71-0 ]
  • [ 71181-82-3 ]
  • 21
  • [ 13093-04-4 ]
  • [ 629-72-1 ]
  • [ 71181-89-0 ]
  • 22
  • [ 1740-58-5 ]
  • [ 13093-04-4 ]
  • 23
  • [ 13093-04-4 ]
  • [ 1675-54-3 ]
  • [ 30215-97-5 ]
  • 24
  • [ 13093-04-4 ]
  • [ 143-15-7 ]
  • [ 58295-87-7 ]
  • 25
  • [ 13093-04-4 ]
  • [ 143-15-7 ]
  • [ 71181-86-7 ]
  • 26
  • [ 124-09-4 ]
  • [ 77-78-1 ]
  • [ 13093-04-4 ]
  • 27
  • [ 13093-04-4 ]
  • [ 112-82-3 ]
  • [ 71181-90-3 ]
  • 28
  • [ 75-15-0 ]
  • [ 13093-04-4 ]
  • [ 78382-97-5 ]
  • 29
  • [ 75-44-5 ]
  • [ 13093-04-4 ]
  • [ 99191-71-6 ]
  • 30
  • [ 527-69-5 ]
  • [ 13093-04-4 ]
  • [ 116784-90-8 ]
YieldReaction ConditionsOperation in experiment
With triethylamine; In dichloromethane; at 0℃; for 2h; 2-Furanoyl chloride (3.75 mL, 38 mmol) was added dropwise, at 0 C., to a mixture of N-tert-butoxycarbonyl-<strong>[13093-04-4]N,N'-dimethyl-1,6-hexanediamine</strong> (9.3 g, 38 mmol) and triethylamine (8.4 mL, 60 mmol) in dichloromethane (120 mL). The resulting mixture was stirred (2 h). The reaction mixture was washed with water (2×20 mL), brine (20 mL), dried over Na2SO4, and concentrated under reduced pressure. The residue was treated with 50% trifluoroacetic acid/dichloromethane (100 mL) overnight. Trifluoroacetic acid and dichloromethane were removed under reduced pressure and the residue was azeotroped with toluene (50 mL). The residue was dissolved in dichloromethane (120 mL), treated carefully with excess NaHCO3 (aqueous), the organic layer separated and the aqueous layer extracted with dichloromethane (2×50 mL). The combined organic layers were washed with water, brine and dried over Na2SO4. After removing the solvent, the residue was dried under vacuum to give the desired product 10 (7.8 g). MH+ 239.2, 1H NMR (CDCl3) delta7.50 (s, 1H), 7.0 (d, 1H), 6.50 (d, 1H), 3.55 (br. s, 3H), 3.0-3.3 (m, 4H), 2.4 5(s, 3H), 1.35-1.75 (m, 8H).
  • 31
  • [ 13093-04-4 ]
  • [ 31250-16-5 ]
  • [ 89806-89-3 ]
  • 32
  • [ 13093-04-4 ]
  • [ 62442-57-3 ]
  • 1,6-bis-N,N'-dimethyl-N,N'-(4'-methylen-4,5',8-trimethylpsoralenyl)hexandiamine [ No CAS ]
  • 33
  • [ 13093-04-4 ]
  • [ 58537-73-8 ]
  • [ 148918-71-2 ]
  • 34
  • [ 13093-04-4 ]
  • [ 117688-86-5 ]
  • [ 117688-88-7 ]
  • 35
  • [ 13093-04-4 ]
  • [ 154798-96-6 ]
  • C83H29N3O3 [ No CAS ]
 

Historical Records

Categories